True Private Wealth Advisors Axogen, Inc. Transaction History

True Private Wealth Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$8.38 - $17.34 $377 - $780	-45 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$11.18 - $18.6 $503 - $837	45 New	45 $0
Q3 2019 Oct 09, 2019	SELL	$12.09 - $20.46 $544 - $920	-45 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$18.5 - $25.47 $832 - $1,146	45 New	45 $0
Q4 2018 Jan 14, 2019	SELL	$17.09 - $38.25 $769 - $1,721	-45 Closed	0 $0

Q3 2018 Oct 18, 2018	BUY	$34.05 - $55.9 $1,532 - $2,515	45 New	45 $0

128

35.4M

80.7K

3.3K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $391M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.